The Use of Lansoprazole to Treat Infants With Symptoms of Gastroesophageal Reflux

NCT00324974 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

162

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastroesophageal Reflux Disease

Interventions

DRUG: Lansoprazole microgranules suspension
DRUG: Placebo

Sponsor

Takeda